Back to search
Male Contraception
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Male Contraception trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Male Contraception trials you may qualify forThis is a Phase 1b/2a open-label, dose escalation 3 part-study, 28-day, 90-day or 180 day repeat dose study of YCT-529 in healthy males who have decided to have…
NLS-133-CLIN001 is a Phase 2a study designed to assess the safety, tolerability, and effects of NLS-133 (combination of two FDA-approved agents) compared to an…
Prospective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive Syst…
This investigation is designed to evaluate the performance rate of two polyurethane male condoms with different sizes and thicknesses versus a standard natural…
This study will evaluate the safety and feasibility of the ADAM System for implantation into the vas deferens in 25 healthy males at 3 sites. This is a prospect…
This is a two-center, open-label study conducted in healthy male and female volunteers at two academic research centers. The study will consist of three single…
The long term objective is to develop a new male hormone Dimethandrolone Undecanoate (DMAU) as a male hormonal contraceptive. The study has two parts. The firs…